Alchemab Therapeutics

Alchemab Therapeutics is a UK-based clinical-stage biotechnology company developing next-generation antibody therapeutics for hard-to-treat diseases. Its "Adaptive Immunity" platform identifies naturally resilient individuals, such as long-term cancer survivors, and harnesses their protective antibodies, using artificial intelligence and deep learning to translate these natural immune responses into novel human-derived therapeutics across neurodegeneration, oncology, and other areas of high unmet need. Alchemab was surfaced as a portfolio company of DCVC and added to the API Evangelist network. As a research-stage therapeutics company it publishes no public developer API program, SDKs, or machine-readable API specifications at this time.

Alchemab Therapeutics is profiled on the APIs.io network. Tagged areas include Company, Biotechnology, Pharmaceuticals, Antibody Therapeutics, and Drug Discovery.

Alchemab Therapeutics’ developer surface includes engineering blog, support, and 4 more developer resources.

🌐 Visit website 📡 Source on GitHub

11.9/100 minimal ▬ flat Agent 0/100 human only Full breakdown ↓
scored 2026-07-27 · rubric v0.5

0 APIs

CompanyBiotechnologyPharmaceuticalsAntibody TherapeuticsDrug DiscoveryArtificial IntelligenceMachine LearningImmunologyLife SciencesHealthcare

Kin Score

Kin Score How this is scored →
scored 2026-07-27 · rubric v0.5

Composite quality — 11.9/100 · minimal

Contract Quality 0.0 / 25

Developer Ergonomics 1.3 / 20

Commercial Clarity 2.1 / 20

Operational Transparency 0.0 / 13

Governance 0.0 / 12

Discoverability 6.8 / 10

Agent readiness — 0/100 · human only

Machine-Readable Contract 0 / 18

Agentic Access Contract 0 / 15

MCP Server 0 / 12

Machine-Readable Auth 0 / 10

Idempotency 0 / 9

Stable Error Semantics 0 / 8

Request/Response Examples 0 / 7

Rate-Limit Signaling 0 / 7

Typed Event Surface 0 / 6

Agent Skills 0 / 5

Well-Known Catalog 0 / 4

Consent & Bot Identity 0 / 3

Improve this rating by publishing the missing artifacts — every area above can be raised, and the full rubric is at apis.io/rating/. This rating is computed from github.com/api-evangelist/alchemab-therapeutics: open an issue to ask a question, or submit a pull request to add artifacts. Want it done for you? Prioritized profiling — $2,500 →

Access & Security 1

Authentication, authorization, and security posture

DomainSecurity

DomainSecurity

Operate 1

Status, limits, changes, and where to get help

Support

Support

Commercial 1

Pricing, plans, and the legal terms of use

PrivacyPolicy

PrivacyPolicy

Company 3

The organization behind the API

Website

Website

About

About

Blog

Blog

Source (apis.yml)

aid: alchemab-therapeutics
accessModel:
  pricing: unknown
  onboarding: unknown
  trial: false
  try_now: false
  public: false
  label: Unknown
  confidence: low
  source: []
  generated: '2026-07-22'
  method: derived
image: https://kinlane-images.s3.amazonaws.com/shared/apis-json/icons/alchemab-therapeutics.png
name: Alchemab Therapeutics
description: Alchemab Therapeutics is a UK-based clinical-stage biotechnology company developing next-generation antibody
  therapeutics for hard-to-treat diseases. Its "Adaptive Immunity" platform identifies naturally resilient individuals, such
  as long-term cancer survivors, and harnesses their protective antibodies, using artificial intelligence and deep learning
  to translate these natural immune responses into novel human-derived therapeutics across neurodegeneration, oncology, and
  other areas of high unmet need. Alchemab was surfaced as a portfolio company of DCVC and added to the API Evangelist network.
  As a research-stage therapeutics company it publishes no public developer API program, SDKs, or machine-readable API specifications
  at this time.
url: https://raw.githubusercontent.com/api-evangelist/alchemab-therapeutics/refs/heads/main/apis.yml
x-type: company
x-source: vc-portfolio
x-backed-by:
- dcvc
x-tier: stub
x-tier-reason: portfolio-lead
specificationVersion: '0.20'
created: '2026-07-17'
modified: '2026-07-17'
tags:
- Company
- Biotechnology
- Pharmaceuticals
- Antibody Therapeutics
- Drug Discovery
- Artificial Intelligence
- Machine Learning
- Immunology
- Life Sciences
- Healthcare
apis: []
common:
- type: DomainSecurity
  url: security/alchemab-therapeutics-domain-security.yml
- type: Website
  url: https://www.alchemab.com/
- type: About
  url: https://www.alchemab.com/about/
- type: Blog
  url: https://www.alchemab.com/news/
- type: Support
  url: https://www.alchemab.com/contact/
- type: PrivacyPolicy
  url: https://www.alchemab.com/privacy-policy/
maintainers:
- FN: Kin Lane
  email: kin@apievangelist.com
- FN: APIs.json
  email: info@apis.io
x-enrichment:
  date: '2026-07-19'
  status: backfilled
  pass: local-v1
  note: backfilled from .gitignore signal + verified work evidence